Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue

Area of Science:

• Biomedical Engineering
• Pharmacology
• Bone Biology

Background:

• Lipid-lowering medications are crucial for cardiovascular risk reduction.
• Potential adverse effects on bone health require thorough investigation.
• Understanding drug-induced changes in bone cytoarchitecture is essential.

Purpose of the Study:

• To evaluate the impact of simvastatin and fenofibrate on bone tissue.
• To assess changes in bone cytoarchitecture, including pore size and connectivity.
• To determine the influence of treatment duration on these effects.

Main Methods:

• Utilized 1D proton magnetic resonance imaging (1H NMR) diffusiometry.
• Employed 2D T2-T2 exchange 1H NMR relaxometry for bone tissue analysis.
• Conducted dynamic evaluations at 14, 16, and 18 weeks in Albino Wistar rats.

Main Results:

• Both fenofibrate and simvastatin demonstrated a decrease in bone strength.
• The reduction in bone strength was more pronounced with extended treatment duration.
• Fenofibrate exhibited more significant negative effects on bone tissue compared to simvastatin.

Conclusions:

• Long-term use of fenofibrate and simvastatin may compromise bone integrity.
• Treatment duration is a critical factor influencing the adverse skeletal effects of these drugs.
• Further research is warranted to explore the clinical implications for patients on lipid-lowering therapy.